{"DataElement":{"publicId":"6229561","version":"1","preferredName":"Cutaneous Melanoma AJCC Edition 8 Clinical Group Stage","preferredDefinition":"Clinical stage group based on the combination of T, N, and M categories and relevant prognostic factors for skin melanoma, using AJCC Ed. 8 criteria.","longName":"CMEL_AJC8_CLN_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6072292","version":"1","preferredName":"Cutaneous Melanoma Clinical Stage Grouping","preferredDefinition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"2431290v1.0:2925061v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2431290","version":"1","preferredName":"Cutaneous Melanoma","preferredDefinition":"A malignant neoplasm derived from cells that are capable of forming melanin.","longName":"C3510","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma","conceptCode":"C3510","definition":"A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF3BE-971D-3B79-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2925061","version":"1","preferredName":"Clinical Stage Grouping","preferredDefinition":"Having to do with the examination and treatment of patients.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25398:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-281E-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65425ECB-E5F8-7A3E-E053-F662850A2DBB","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-15","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 2/15/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6229540","version":"1","preferredName":"Cutaneous Melanoma American Joint Committee on Cancer Edition 8 Clinical Group Stage","preferredDefinition":"A term that refers to the clinical staging of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6229540v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Clinical Stage IV Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229542","version":"1","preferredName":"Clinical Stage IV Cutaneous Melanoma AJCC v8","longName":"6229542","preferredDefinition":"Stage IV includes: Any T, Any N, M1. M1: Evidence of distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IV Cutaneous Melanoma AJCC v8","conceptCode":"C137656","definition":"Stage IV includes: Any T, Any N, M1. M1: Evidence of distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-3891-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-38AA-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"III","valueDescription":"Clinical Stage III Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229544","version":"1","preferredName":"Clinical Stage III Cutaneous Melanoma AJCC v8","longName":"6229544","preferredDefinition":"Stage III includes: Any T, Tis, N1 or More, M0. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. N1: One tumor-involved node or in-transit, satellite, and/or microsatellite metastases with no tumor-involved nodes. N2: Two or three tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with one tumor-involved node. N3: Four or more tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage III Cutaneous Melanoma AJCC v8","conceptCode":"C137655","definition":"Stage III includes: Any T, Tis, N1 or More, M0. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. N1: One tumor-involved node or in-transit, satellite, and/or microsatellite metastases with no tumor-involved nodes. N2: Two or three tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with one tumor-involved node. N3: Four or more tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-38B7-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-38D0-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"IIC","valueDescription":"Clinical Stage IIC Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229546","version":"1","preferredName":"Clinical Stage IIC Cutaneous Melanoma AJCC v8","longName":"6229546","preferredDefinition":"Stage IIC includes: T4b, N0, M0. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration.  N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IIC Cutaneous Melanoma AJCC v8","conceptCode":"C137654","definition":"Stage IIC includes: T4b, N0, M0. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration.  N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-38DD-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-38F6-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Clinical Stage IIB Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229548","version":"1","preferredName":"Clinical Stage IIB Cutaneous Melanoma AJCC v8","longName":"6229548","preferredDefinition":"Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0). T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IIB Cutaneous Melanoma AJCC v8","conceptCode":"C137653","definition":"Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0). T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-3903-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-391C-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Clinical Stage IIA Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229550","version":"1","preferredName":"Clinical Stage IIA Cutaneous Melanoma AJCC v8","longName":"6229550","preferredDefinition":"Stage IIA includes: (T2b, N0, M0); (T3a, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IIA Cutaneous Melanoma AJCC v8","conceptCode":"C137652","definition":"Stage IIA includes: (T2b, N0, M0); (T3a, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-3929-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-3942-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"II","valueDescription":"Clinical Stage II Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229552","version":"1","preferredName":"Clinical Stage II Cutaneous Melanoma AJCC v8","longName":"6229552","preferredDefinition":"Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration.  N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage II Cutaneous Melanoma AJCC v8","conceptCode":"C137651","definition":"Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration.  N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-394F-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-3968-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"IB","valueDescription":"Clinical Stage IB Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229554","version":"1","preferredName":"Clinical Stage IB Cutaneous Melanoma AJCC v8","longName":"6229554","preferredDefinition":"Stage IB includes: (T1b, N0, M0); (T2a, N0, M0). T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IB Cutaneous Melanoma AJCC v8","conceptCode":"C137650","definition":"Stage IB includes: (T1b, N0, M0); (T2a, N0, M0). T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-3975-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-398E-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"IA","valueDescription":"Clinical Stage IA Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229556","version":"1","preferredName":"Clinical Stage IA Cutaneous Melanoma AJCC v8","longName":"6229556","preferredDefinition":"Stage IA includes: T1a, N0, M0. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IA Cutaneous Melanoma AJCC v8","conceptCode":"C137649","definition":"Stage IA includes: T1a, N0, M0. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-399B-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-39B4-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"I","valueDescription":"Clinical Stage I Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229558","version":"1","preferredName":"Clinical Stage I Cutaneous Melanoma AJCC v8","longName":"6229558","preferredDefinition":"Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2a, N0, M0). T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage I Cutaneous Melanoma AJCC v8","conceptCode":"C137648","definition":"Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2a, N0, M0). T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-39C1-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-39DA-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"},{"value":"0","valueDescription":"Clinical Stage 0 Cutaneous Melanoma AJCC v8","ValueMeaning":{"publicId":"6229560","version":"1","preferredName":"Clinical Stage 0 Cutaneous Melanoma AJCC v8","longName":"6229560","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage 0 Cutaneous Melanoma AJCC v8","conceptCode":"C137647","definition":"Stage 0 includes: Tis, N0, M0. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-39E7-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A868D91-3A00-57B2-E053-F662850A8432","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6229539","version":"1","preferredName":"Cutaneous Melanoma by AJCC v8 Clinical Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the clinical staging of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C137646:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Melanoma by AJCC v8 Clinical Stage","conceptCode":"C137646","definition":"A term that refers to the clinical staging of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A868D91-3864-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"ONEDATA","dateModified":"2018-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6A868D91-3875-57B2-E053-F662850A8432","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 4/23/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000090","version":"1","longName":"Cutaneous Melanoma","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical disease stage","type":"Preferred Question Text","description":"Clinical disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6A88DBC9-1B75-7C97-E053-F662850A6845","latestVersionIndicator":"Yes","beginDate":"2018-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-23","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 4/23/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}